Artificial intelligence (AI) is transforming healthcare across multiple fields, and prostate cancer (PCa)  is no exception. A ...

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" ...

ASCO 2025, prostate cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), enzalutamide, 8-Year Outcomes of Enzalutamide Versus a Non-Steroidal Anti-Androgen, ENZAMET trial, ANZUP 1304 trial.

Comparative experiments unveiled that the proposed model outperformed conventional DL architectures in lung cancer detection. The proposed system, utilizing advanced attention mechanisms and ...

Lung cancer remains a leading cause of mortality, emphasizing the crucial need for early detection to improve survival rates. Computed tomography (CT) imaging stands out as a pivotal strategy in this ...

AbstractTo explore how early cancers can be detected prior to clinical signs or symptoms, we assessed prospectively collected serial plasma samples from the Atherosclerosis Risk in Communities study, ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

LOS ANGELES, CALIF. – (July 2, 2025) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer, today announced a new data partnership ...